Ftse Mib
37.677,27
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.623,50
0,16%
NASDAQ
17.667,25
1,14%
Bitcoin
83.178,24
5,97%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adial Pharmaceuticals Inc (ADIL) Adial Pharmaceuticals Inc (ADIL) Notizie

Adial Pharmaceuticals Inc

ADIL
0,6615
-0,0585 (-8,12%)
Ultimo aggiornamento: 19:55:02
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202522:15EDGAR2Form 8-K - Current report
04/3/202514:57EDGAR2Form 8-K - Current report
04/3/202514:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202514:30GLOBEAdial Pharmaceuticals Reports 2024 Fiscal Year Financial..
25/2/202515:15EDGAR2Form 8-K - Current report
25/2/202515:00GLOBEAdial Pharmaceuticals Receives Positive Response from FDA..
19/2/202515:00GLOBEAdial Pharmaceuticals Granted New U.S. Patent Expanding..
12/2/202515:00GLOBEAdial Pharmaceuticals Awarded New U.S. Patent Covering..
29/1/202515:00GLOBEAdial Pharmaceuticals Announces Positive Clinical Study..
13/1/202514:33EDGAR2Form 8-K - Current report
08/1/202522:38EDGAR2Form 8-K - Current report
31/12/202416:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
20/12/202422:01EDGAR2Form S-1 - General form for registration of securities under..
18/12/202423:00EDGAR2Form 8-K - Current report
12/12/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202423:07EDGAR2Form 8-K - Current report
03/12/202414:30GLOBEAdial Pharmaceuticals Granted Key U.S. Patent for the..
18/11/202422:01EDGAR2Form 8-K - Current report
18/11/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202421:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:30GLOBEAdial Pharmaceuticals Announces Positive Topline Results..
13/11/202422:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:30GLOBEAdial Pharmaceuticals Reports Third Quarter 2024 Financial..
12/11/202422:12EDGAR2Form 8-K - Current report
05/11/202414:45EDGAR2Form 8-K - Current report
05/11/202414:30GLOBEAdial Pharmaceuticals Appoints Vinay Shah as Chief Financial..
23/10/202415:00GLOBEAdial Pharmaceuticals to Present at the 2024 ThinkEquity..
17/10/202415:00GLOBEAdial Pharmaceuticals Receives Notice of Allowance for U.S...
15/10/202415:00GLOBEAdial Pharmaceuticals Commends the National Institute on..
27/9/202423:20EDGAR2Form DEF 14A - Other definitive proxy statements
19/9/202414:30GLOBEAdial Pharmaceuticals Announces Database Lock in..
04/9/202415:00GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 26th..
14/8/202414:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2024 Financial..
13/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202415:00GLOBEAdial Pharmaceuticals Signs Agreement with Boudicca Dx to..
07/8/202415:00GLOBEAdial Pharmaceuticals Announces Last Patient Dosed in..
31/7/202414:30GLOBEAdial Pharmaceuticals Files New Patent Application to..
23/7/202414:30GLOBEAdial Pharmaceuticals Advances to Second Cohort in..
20/6/202414:30GLOBEAdial Pharmaceuticals Announces Publication in Leading..
05/6/202414:30GLOBEAdial Pharmaceuticals Achieves Important Milestone of First..
29/5/202414:30GLOBEAdial CEO to Present at the Spring MicroCap Rodeo Conference..
15/5/202414:30GLOBEAdial Pharmaceuticals Reports First Quarter 2024 Financial..
14/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/4/202414:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/4/202414:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/4/202414:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
Apertura: 0,704 Min: 0,658 Max: 0,754
Chiusura: 0,72

La tua Cronologia

NASDAQ
ADIL
Adial Pharmaceuticals
TSXV
LTH
Lithium Ionic
AQSE
NANO.GB
Nanoco
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci